• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用皮内注射卡介苗和热灌注治疗下肢黑色素瘤。

Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion.

作者信息

Storm F K, Sparks F C, Morton D L

出版信息

Surg Gynecol Obstet. 1979 Jul;149(1):17-21.

PMID:451822
Abstract

Twenty-seven patients with locally recurrent melanoma of the lower extremity were treated during a six year period. Recurrences were noted with primary lesions, at Clark's level II, III, IV or V, greater than 1.7 millimeters in depth of invasion and included intransit metastases, satellitosis, subcutaneous metastases and combinations of the three. Median time to recurrence was 12 to 14 months whether or not lymphadenectomy had been performed or lymph node metastases were present. Local recurrence was treated initially with intratumor bacille Calmette Guérin; 20 of 27 patients had complete or transient disease control and 14 patients were alive at 1.5 to 55.0 months. More responders reacted to dinitrochlorobenzene and purified protein derivative skin tests, although these parameters did not predict response to therapy. If intratumor bacille Calmette Guérin therapy did not control local disease or if the disease progressed toward the upper third of the thigh, patients underwent hyperthermic perfusion with L-phenylalanine mustard. Nine patients underwent ten therapeutic perfusions with objective response in seven of nine, with five being alive at two to 65 months. Intratumor bacille Calmette Guérin therapy and subsequent hyperthermic perfusion in bacille Calmette Guérin failures are rational treatment alternatives for locally recurrent melanomas of the extremity.

摘要

在六年期间,对27例下肢局部复发性黑色素瘤患者进行了治疗。复发见于原发性病变,处于克拉克分级II、III、IV或V级,浸润深度大于1.7毫米,包括皮肤转移、卫星灶、皮下转移以及三者的组合。无论是否进行了淋巴结清扫术或存在淋巴结转移,复发的中位时间为12至14个月。局部复发最初采用瘤内注射卡介苗治疗;27例患者中有20例疾病得到完全或暂时控制,14例患者在1.5至55.0个月时仍存活。更多的反应者对二硝基氯苯和纯化蛋白衍生物皮肤试验有反应,尽管这些参数不能预测对治疗的反应。如果瘤内注射卡介苗治疗不能控制局部疾病,或者疾病进展至大腿上三分之一处,患者则接受左旋苯丙氨酸氮芥热灌注治疗。9例患者接受了10次治疗性灌注,9例中有7例有客观反应,5例在2至65个月时仍存活。对于肢体局部复发性黑色素瘤,瘤内注射卡介苗治疗以及卡介苗治疗失败后的后续热灌注是合理的治疗选择。

相似文献

1
Treatment for melanoma of the lower extremity with intralesional injection of bacille Calmette Guérin and hyperthermic perfusion.采用皮内注射卡介苗和热灌注治疗下肢黑色素瘤。
Surg Gynecol Obstet. 1979 Jul;149(1):17-21.
2
Hyperthermic perfusion of recurrent malignant melanoma on the extremities.肢体复发性恶性黑色素瘤的热灌注治疗
Acta Chir Scand. 1980;146(5):313-8.
3
Prophylactic hyperthermic limb perfusion in stage I melanoma.I期黑色素瘤的预防性肢体热灌注
Eur J Surg Oncol. 1988 Aug;14(4):321-6.
4
Hyperthermic isolated regional perfusion of the limb with carboplatin.肢体卡铂热灌注隔离区域灌注术。
Eur J Surg Oncol. 2000 Dec;26(8):792-7. doi: 10.1053/ejso.2000.1006.
5
Oral bacille Calmette Guérin immunostimulation in malignant melanoma.卡介苗口服免疫刺激在恶性黑色素瘤中的作用
Surg Gynecol Obstet. 1975 Nov;141(5):747-54.
6
Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.肢体恶性黑色素瘤手术后顺铂区域热灌注治疗
Am J Surg. 1996 Apr;171(4):416-20. doi: 10.1016/S0002-9610(97)89621-3.
7
Randomized controlled trial of adjuvant chemoimmunotherapy with DTIC and BCG after complete excision of primary melanoma with a poor prognosis or melanoma metastases.对预后不良的原发性黑色素瘤或黑色素瘤转移灶进行完全切除后,采用达卡巴嗪(DTIC)和卡介苗(BCG)进行辅助化学免疫治疗的随机对照试验。
Can Med Assoc J. 1983 Apr 15;128(8):929-33.
8
[Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].[肢体原发性恶性黑色素瘤的区域灌注治疗。(根据克拉克分级为微分期IV/V且肿瘤厚度超过1.5毫米)]
Hautarzt. 1982 Sep;33(9):506-10.
9
[Isolated hyperthermic antiblastic perfusion in recurrent melanoma of the extremities].[肢体复发性黑色素瘤的孤立性高温抗瘤灌注]
Minerva Chir. 1994 Jul-Aug;49(7-8):681-91.
10
Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma.黑色素瘤高危患者的辅助化疗和免疫治疗
Surg Gynecol Obstet. 1978 Feb;146(2):230-2.

引用本文的文献

1
Therapeutic Treatment Options for In-Transit Metastases from Melanoma.黑色素瘤皮肤转移的治疗选择
Cancers (Basel). 2024 Sep 3;16(17):3065. doi: 10.3390/cancers16173065.
2
Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.恶性黑色素瘤:在全身治疗日益有效的时代中不断发展的实践管理
Curr Probl Surg. 2022 Jan;59(1):101030. doi: 10.1016/j.cpsurg.2021.101030. Epub 2021 Jul 7.
3
Neoadjuvant treatment for melanoma: current challenges and future perspectives.黑色素瘤的新辅助治疗:当前挑战与未来展望。
Melanoma Manag. 2016 Jun;3(2):149-159. doi: 10.2217/mmt-2015-0001. Epub 2016 May 25.
4
Developments in Intralesional Therapy for Metastatic Melanoma.转移性黑色素瘤瘤内治疗的进展
Cancer Control. 2016 Jan;23(1):12-20. doi: 10.1177/107327481602300104.
5
Management of malignant melanoma.恶性黑色素瘤的管理
Arch Plast Surg. 2012 Sep;39(5):565-74. doi: 10.5999/aps.2012.39.5.565. Epub 2012 Sep 12.
6
Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.使用新型多价黑色素瘤疫苗进行主动特异性免疫治疗后转移性黑色素瘤患者生存期的延长
Ann Surg. 1992 Oct;216(4):463-82. doi: 10.1097/00000658-199210000-00010.